RenovoRx, Inc.
RNXT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $48,281 | $31,082 | $28,730 |
| - Cash | $10,044 | $12,314 | $14,582 | $7,154 |
| + Debt | $134 | $260 | $283 | $278 |
| Enterprise Value | – | $36,227 | $16,783 | $21,854 |
| Revenue | $266 | $422 | $197 | $43 |
| % Growth | -37% | 114.2% | 358.1% | – |
| Gross Profit | $213 | $270 | $103 | $43 |
| % Margin | 80.1% | 64% | 52.3% | 100% |
| EBITDA | -$2,911 | -$2,677 | -$2,419 | $0 |
| % Margin | -1,094.4% | -634.4% | -1,227.9% | 0% |
| Net Income | -$2,912 | -$2,895 | -$2,420 | -$2,878 |
| % Margin | -1,094.7% | -686% | -1,228.4% | -6,693% |
| EPS Diluted | -0.08 | -0.079 | -0.077 | -0.13 |
| % Growth | -1% | -2.7% | 40.7% | – |
| Operating Cash Flow | -$2,270 | -$2,302 | -$3,381 | -$2,430 |
| Capital Expenditures | $0 | $0 | -$2 | -$12 |
| Free Cash Flow | -$2,270 | -$2,302 | -$3,383 | -$2,442 |